Back

TLR3 Activation of Microglia-Containing Cerebral Organoid Induces Antiviral Factors against HIV-1 Infection

Xiao, Q.; Wang, X.; Sarkar, P.; Wang, X.-L.; Song, L.; Ling, B.; Hu, W.-H.; Ho, W.

2025-12-19 immunology
10.64898/2025.12.17.695025 bioRxiv
Show abstract

Human induced pluripotent stem cell (iPSC)-derived cerebral organoids have been increasingly used as a brain model for studying various neurological disorders and neurotropic virus infections, including HIV-1. However, it is unclear whether iPSC-derived cerebral organoids possess functional innate antiviral immunity against HIV-1. In this study, we examined Toll-Like Receptor 3 (TLR3) activation and its role in the induction of IFNs and IFN-stimulated genes (ISGs) against HIV-1 in human iPSC-derived microglia containing cerebral organoids (MCOs). We observed that MCOs possess functional TLR3, which could be effectively activated by poly I:C. TLR3 activation of MCOs resulted in HIV-1 inhibition and induction of IFN-{beta}/IFN-{lambda}, antiviral ISGs (MX1, MX2, GBP5, SAMHD1, Viperin, and ISG56), and CC chemokines (MIP-1, MIP-1{beta}, and RANTES), the ligands for HIV entry coreceptor CCR5. This TLR3 activation-mediated anti-HIV-1 effects could be blocked by a specific TLR3 inhibitor. These findings indicate that human iPSC-derived MCOs are a suitable model for investigation of brain immunity and HIV-1 infection.

Published in Frontiers in Pharmacology · training set

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.